The Impact of Vitamin D in Non-Alcoholic Fatty Liver Disease: A Cross-Sectional Study in Patients with Morbid Obesity

Código QR

The Impact of Vitamin D in Non-Alcoholic Fatty Liver Disease: A Cross-Sectional Study in Patients with Morbid Obesity

Marta Borges-Canha,1,2 João Sérgio Neves,1,2 Fernando Mendonça,1 Maria Manuel Silva,1 Cláudia Costa,3 Pedro M Cabral,4 Vanessa Guerreiro,1 Rita Lourenço,5 Patrícia Meira,5 Daniela Salazar,1 Maria João Ferreira,1 Jorge Pedro...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Borges-Canha M, Neves JS, Mendonça F, Silva MM, Costa C, Cabral PM, Guerreiro V, Lourenço R, Meira P, Salazar D, Ferreira MJ, Pedro J, Leite AR, von-Hafe M, Vale C, Viana S, Sande A, Belo S, Lau E, Freitas P, Carvalho D
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2021
Materias:	vitamin d fatty liver nafld obesity Specialties of internal medicine RC581-951
Acceso en línea:	https://doaj.org/article/45039f69f760485caeaebf29742a7632
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Correlation between Non-Alcoholic Fatty Liver Disease (NAFLD) fibrosis score (NFS) with Left Ventricular Mass Index (LVMI) in patients with NAFLD
por: Tri Ferry Rachmatullah, et al.
Publicado: (2021)

Hepatoprotective Effects of Tribulus terrestris Hydro-Alcholic Extract on Non-Alcoholic Fatty Liver- Induced Rats
por: Almasi,Fatemeh, et al.
Publicado: (2017)

Differential Therapeutic Effects of Crataegus aronia and Simvastatin on the Hepatocyte Ultrastructure in Hepatic Steatosis
por: Al Humayed,Suliman, et al.
Publicado: (2017)

Effect of Probiotic Supplementation on Sprague Dawley Rat Liver Histopathology Fed by High Fat High Fructose Diet
por: Ninung Rose Diana Kusumawati, et al.
Publicado: (2021)

State of gut microbiota and dietary preferences in obese adolescents
por: L.K. Parkhomenko, et al.
Publicado: (2020)

A Review Of Current And Upcoming Treatment Modalities In Non-Alcoholic Fatty Liver Disease And Non-Alcoholic Steatohepatitis
por: Ganguli S, et al.
Publicado: (2019)

Plant-derived oleanolic acid ameliorates markers associated with non-alcoholic fatty liver disease in a diet-induced pre-diabetes rat model
por: Gamede M, et al.
Publicado: (2019)

Loss of progesterone receptor membrane component 1 promotes hepatic steatosis via the induced de novo lipogenesis
por: Sang R. Lee, et al.
Publicado: (2018)

Dietary Intervention Reverses Fatty Liver and Altered Gut Microbiota during Early-Life Undernutrition
por: K. C. Bauer, et al.
Publicado: (2020)

Circulatory <i>Endothelin 1-</i>Regulating RNAs Panel: Promising Biomarkers for Non-Invasive NAFLD/NASH Diagnosis and Stratification: Clinical and Molecular Pilot Study
por: Reda Albadawy, et al.
Publicado: (2021)

Genetics, Immunity and Nutrition Boost the Switching from NASH to HCC
por: Paola Dongiovanni, et al.
Publicado: (2021)

Analysis of Common Pathways and Markers From Non-Alcoholic Fatty Liver Disease to Immune-Mediated Diseases
por: Rocío Gallego-Durán, et al.
Publicado: (2021)

Effect of cranberry supplementation on liver enzymes and cardiometabolic risk factors in patients with NAFLD: a randomized clinical trial
por: Kourosh Masnadi Shirazi, et al.
Publicado: (2021)

Changes in Serum Nesfatin-1 After Laparoscopic Sleeve Gastrectomy are Associated with Improvements in Nonalcoholic Fatty Liver Disease
por: Yang K, et al.
Publicado: (2020)

Role of Ferroptosis in Non-Alcoholic Fatty Liver Disease and Its Implications for Therapeutic Strategies
por: Han Zhang, et al.
Publicado: (2021)

Machine Learning-Based Identification of Potentially Novel Non-Alcoholic Fatty Liver Disease Biomarkers
por: Roshan Shafiha, et al.
Publicado: (2021)

Targeting T Cell Subtypes for NAFLD and NAFLD-Related HCC Treatment: An Opinion
por: Chunye Zhang, et al.
Publicado: (2021)

The Circulating Micro-RNAs (−122, −34a and −99a) as Predictive Biomarkers for Non-Alcoholic Fatty Liver Diseases
por: Hendy OM, et al.
Publicado: (2019)

Ethnic differences and heterogeneity in genetic and metabolic makeup contributing to nonalcoholic fatty liver disease
por: Szanto KB, et al.
Publicado: (2019)

COMPARISON OF SERUM FERRITIN LEVELS IN NAFLD PATIENTS AND HEALTHY CONTROLS
por: Mehwish Qamar, et al.
Publicado: (2020)

Carminic acid mitigates fructose-triggered hepatic steatosis by inhibition of oxidative stress and inflammatory reaction
por: Ling Li, et al.
Publicado: (2022)

Relationship Between Helicobacter pylori Infection and Nonalcoholic Fatty Liver Disease (NAFLD) in a Developing Country: A Cross-Sectional Study
por: Abo-Amer YEE, et al.
Publicado: (2020)

PI3Kγ promotes obesity-associated hepatocellular carcinoma by regulating metabolism and inflammation
por: Barbara Becattini, et al.
Publicado: (2021)

Clinical and Molecular Biomarkers for Diagnosis and Staging of NAFLD
por: Stefania Di Mauro, et al.
Publicado: (2021)

Network Pharmacology Exploration Reveals Anti-Apoptosis as a Common Therapeutic Mechanism for Non-Alcoholic Fatty Liver Disease Treated with Blueberry Leaf Polyphenols
por: Cai-Ren Wang, et al.
Publicado: (2021)

Bile acids contribute to the development of non-alcoholic steatohepatitis in mice
por: Justine Gillard, et al.
Publicado: (2022)

Analysis Of Risk Factors For Nonalcoholic Fatty-Liver Disease In Hepatitis B Virus Infection: A Case–Control Study
por: Azarkar G, et al.
Publicado: (2019)

SP-1154, a novel synthetic TGF-β inhibitor, alleviates obesity and hepatic steatosis in high-fat diet-induced mice
por: Kisoo Pahk, et al.
Publicado: (2022)

Biochanin A Regulates Cholesterol Metabolism Further Delays the Progression of Nonalcoholic Fatty Liver Disease
por: Fan Y, et al.
Publicado: (2021)

Risk of Non-Alcoholic Fatty Liver Disease in Xanthelasma Palpebrarum
por: Chen HW, et al.
Publicado: (2021)

Involvement of Ceramides in Non-Alcoholic Fatty Liver Disease (NAFLD) Atherosclerosis (ATS) Development: Mechanisms and Therapeutic Targets
por: Daniela Maria Tanase, et al.
Publicado: (2021)

Aqueous Metabolite Trends for the Progression of Nonalcoholic Fatty Liver Disease in Female Bariatric Surgery Patients by Targeted <sup>1</sup>H-NMR Metabolomics
por: Emma J. Robinson, et al.
Publicado: (2021)

Gut Microbiota Reshaped by Pectin Treatment Improves Liver Steatosis in Obese Mice
por: Camille Houron, et al.
Publicado: (2021)

Effect of a common missense variant in LIPA gene on fatty liver disease and lipid phenotype: New perspectives from a single‐center observational study
por: Andrea Pasta, et al.
Publicado: (2021)

Polygoni Multiflori Radix Praeparata Ethanol Extract Exerts a Protective Effect Against High-Fat Diet Induced Non-Alcoholic Fatty Liver Disease in Mice by Remodeling Intestinal Microbial Structure and Maintaining Metabolic Homeostasis of Bile Acids
por: Xuyang Dai, et al.
Publicado: (2021)

Universal Index for Cirrhosis (UIC index): The development and validation of a novel index to predict advanced liver disease
por: Ahmed Z, et al.
Publicado: (2018)

The Impact of Dysmetabolic Sarcopenia Among Insulin Sensitive Tissues: A Narrative Review
por: Angelo Armandi, et al.
Publicado: (2021)

Gender differences in relation to hyperuricemia and nonalcoholic fatty liver disease among Type 2 diabetics in Telangana, India
por: Usha Sree Puneem, et al.
Publicado: (2021)

Pleiotropic actions of IP6K1 mediate hepatic metabolic dysfunction to promote nonalcoholic fatty liver disease and steatohepatitis
por: Sandip Mukherjee, et al.
Publicado: (2021)

Diabetes, metabolic syndrome and dyslipidemia in people living with HIV in Africa: re-emerging challenges not to be forgotten
por: Husain NE, et al.
Publicado: (2017)